Zydus Lifesciences Ltd.

BSE: 532321 | NSE: ZYDUSLIFE

Mid Cap | Pharmaceuticals & Drugs

928.60

-7.75 (-0.83%)

< Home < Back

Zydus Lifesciences Ltd. News

>>

Zydus Lifesciences inches up on receiving final approval from USFDA for Norepinephrine Bitartrate Injection

>>

Zydus Lifesciences receives final approval from USFDA for Norepinephrine Bitartrate Injection

>>

Zydus Lifesciences informs about press release

>>

Zydus Lifesciences informs about press release

>>

Zydus Lifesciences’ arm gets USFDA’s final approval for Efinaconazole Topical Solution

>>

Zydus Lifesciences informs about newspaper cutting

>>

Zydus Lifesciences jumps on launching Sitaglyn and Siglyn for management of Type 2 diabetes

>>

Zydus gets final approval from USFDA for Empagliflozin and Metformin Hydrochloride Tablets

>>

Zydus Lifesciences informs about press release

>>

Zydus Lifesciences launches Sitaglyn and Siglyn for management of Type 2 diabetes

<< < 62 63 64 ...168 > >>